Edesa Biotech, Inc.
EDSA · NASDAQ
9/30/2025 | 9/30/2024 | 9/30/2023 | 9/30/2022 | |
|---|---|---|---|---|
| Market Cap | – | $14 | $13 | $13 |
| - Cash | $11 | $1 | $5 | $7 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | – | $13 | $7 | $6 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | – | – | – |
| EBITDA | -$7 | -$6 | -$8 | -$17 |
| % Margin | – | – | – | – |
| Net Income | -$7 | -$6 | -$8 | -$18 |
| % Margin | – | – | – | – |
| EPS Diluted | -1.27 | -1.93 | -2.93 | -8.37 |
| % Growth | 34.2% | 34.1% | 65% | – |
| Operating Cash Flow | -$7 | -$5 | -$7 | -$12 |
| Capital Expenditures | $0 | $0 | $0 | -$0 |
| Free Cash Flow | -$7 | -$5 | -$7 | -$12 |